1. Home
  2. CHEK vs JAGX Comparison

CHEK vs JAGX Comparison

Compare CHEK & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • JAGX
  • Stock Information
  • Founded
  • CHEK 2004
  • JAGX 2013
  • Country
  • CHEK Israel
  • JAGX United States
  • Employees
  • CHEK N/A
  • JAGX N/A
  • Industry
  • CHEK Medical Electronics
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • JAGX Health Care
  • Exchange
  • CHEK Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • CHEK 3.9M
  • JAGX 3.9M
  • IPO Year
  • CHEK 2015
  • JAGX N/A
  • Fundamental
  • Price
  • CHEK $1.24
  • JAGX $1.68
  • Analyst Decision
  • CHEK
  • JAGX Strong Buy
  • Analyst Count
  • CHEK 0
  • JAGX 1
  • Target Price
  • CHEK N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • CHEK 98.8K
  • JAGX 81.6K
  • Earning Date
  • CHEK 11-28-2025
  • JAGX 11-14-2025
  • Dividend Yield
  • CHEK N/A
  • JAGX N/A
  • EPS Growth
  • CHEK N/A
  • JAGX N/A
  • EPS
  • CHEK N/A
  • JAGX N/A
  • Revenue
  • CHEK N/A
  • JAGX $11,810,000.00
  • Revenue This Year
  • CHEK N/A
  • JAGX $22.41
  • Revenue Next Year
  • CHEK N/A
  • JAGX $30.00
  • P/E Ratio
  • CHEK N/A
  • JAGX N/A
  • Revenue Growth
  • CHEK N/A
  • JAGX 15.96
  • 52 Week Low
  • CHEK $0.56
  • JAGX $1.57
  • 52 Week High
  • CHEK $3.13
  • JAGX $33.25
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 34.47
  • JAGX 34.96
  • Support Level
  • CHEK $1.29
  • JAGX $1.77
  • Resistance Level
  • CHEK $1.35
  • JAGX $2.00
  • Average True Range (ATR)
  • CHEK 0.10
  • JAGX 0.14
  • MACD
  • CHEK -0.05
  • JAGX -0.04
  • Stochastic Oscillator
  • CHEK 1.75
  • JAGX 3.64

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: